Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details

Bulletin Express

11/07

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.

The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/1120115825"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1120115825\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1120115825?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-07 16:22","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1120115825","market":"hk","top_or_hot":-1,"title":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details","media":"Bulletin Express","content":"<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nShanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) Announces 2025 Second Extraordinary General Meeting Details\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-07 16:22</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.</p>\n<p>The meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02196","symbol_name":"复星医药","start_time":0,"source_url":"","article_id":"1120115825","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1120115825","pubTimestamp":1762503734,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02196":"复星医药"},"translate_title":"上海复星医药（集团）股份有限公司(02196)公布2025年第二次临时股东大会详情","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02196":1},"content_text":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (02196) has officially released a proxy form related to its upcoming 2025 second extraordinary general meeting (EGM). According to the announcement, the EGM is scheduled for Tuesday, 2 December 2025, at 1:30 p.m. (Beijing time) at the Sky Fortune Boutique Hotel Shanghai, No. 358 Hong Xu Road, Shanghai.\nThe meeting agenda includes the consideration of an ordinary resolution to elect Mr. Liu Yi as an executive Director. H Shareholders may appoint the chairman of the meeting or another proxy to vote on their behalf. The proxy form, along with any authorizing documents, must be submitted to the designated Hong Kong share registrar no later than 24 hours before the start of the meeting. Shareholders who have submitted proxy forms retain the right to attend and vote at the EGM should they choose to do so.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}